Dr. Barbara Waszczak, Professor of Pharmacology at Northeastern University s Bouvé College of Health Sciences, is the Principal Investigator and Project.
An initial $6.7 million grant comes from the National Institute on Drug Abuse, part of the National Institutes of Health. Copernicus, a clinical-stage gene therapy company in Cleveland, and Northeastern, which is in Boston, said the grant has the potential for an additional $8 million in Phase 2 funding 'to further move the gene therapy toward clinical trials.'
Share this article
Share this article
ResearchAndMarkets.com s offering.
Report Highlights
The Parkinson s Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson s Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 11, 48, 62, 4, 224, 97 and 9 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 1, 52 and 19 molecules, respectively.
The Parkinson s Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter-strategies to gain competitive adva
Press release content from Wired Release. The AP news staff was not involved in its creation.
Juvenile Macular Degeneration Treatment Market 2021 – Global Research, Recent Trends and Growth Forecast To 2026
December 17, 2020 GMT
Pune, Maharashtra, India, December 17 2020 (Wiredrelease) MarketDesk :The research report Global Juvenile Macular Degeneration Treatment Market Industry Analysis 2021-2026 covers all the major trends and drivers playing a key part in the development of the Life Sciences industry. The analysis gives an extensive investigation of market growth in terms of value (US$ Mn) and volume (units) throughout the above forecast period. The report emphasizes market dynamics which offers the study of market drivers, restraints, opportunities, major trends, technology advancements, policy, and regulations. These expected to give a major impact on Juvenile Macular Degeneration Treatment market growth during the period of COVID-19 outbreak.